Opzelura is under clinical development by Incyte and currently in Phase II for Seborrhea. According to GlobalData, Phase II drugs for Seborrhea have a 57% phase transition success rate (PTSR) ...
Hosted on MSN24y
Difference Between Seborrheic Dermatitis and Scalp PsoriasisMedically reviewed by William Truswell, MD It can be difficult to tell the difference between seborrheic dermatitis vs. psoriasis when symptoms appear only on the scalp. Both conditions can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback